Liven Pharma Limited - LIVEN

Rs 34.02

Change -0.97

On Feb 27

Trades end of day

Last trade on Feb 27, 2026 Day's range Rs 32.47 - 34.99
Change Rs -0.97 52 week range Rs 32.47 - 108.24
Open Rs 34.99 Volume 70,571
Close Rs 34.02 Previous Close Rs 34.02

LIVEN Company Meetings

No Meetings
 

LIVEN Trade Activity

Period High Low Volume
1M 54.15 34.02 7,739,632.00; Avg 368,553.90
3M 56.56 34.02 16,027,962.00; Avg 254,412.10
6M 71.31 34.02 32,684,770.00; Avg 253,370.31
1Y 102.42 34.02 92,794,743.00; Avg 372,669.65
 
 

Latest Annual Financials

Financial Year O/S Shares 0.00m
Net Profit Rs 0.00m Market Cap Rs 0.00m
EPS 0.00 P/E 0.00
Par Value Rs 0.00 Book Value 0.00
Net Worth Rs 0.00m Outstanding Shares 0.00m
Dividend Rs 0.00 ROE 0.00%
Dividend Yield 0.00% Divident Payout 0.00%
Earnings Yield 0.00% Sharia No
 

Price Chart

Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools, stock screener and real time economic calendar data to track key financial events.

 

The company is in the Pharmaceuticals sector.

 

Other Companies in This Sector

Company Current Change Date
Abbot Laboratories Rs 1,029.76 -1.46% Feb 27, 2026
AGP Limited Rs 218.09 -1.76% Feb 27, 2026
BF Biosciences Limited Rs 153.23 -1.45% Feb 27, 2026
Citi Pharma Limited Rs 84.16 0.49% Feb 27, 2026
Ferozsons Laboratories Limited Rs 405.77 -2.53% Feb 27, 2026
Glaxosmithkline Rs 372.62 -1.44% Feb 27, 2026
Glaxo Healthcare Pakistan Rs 120.23 -3.20% Jan 30, 2023
Haleon Pakistan Limited Rs 873.65 0.18% Feb 27, 2026
Highnoon Laboratories Rs 971.91 2.52% Feb 27, 2026
Hoechst Pakistan Limited Rs 4,240.66 -1.38% Feb 27, 2026
IBL Healthcare Limited Rs 43.37 0.86% Feb 27, 2026
IBL Healthcare Limited (r) Rs 0.00 0.00% Feb 28, 2026
Liven Pharma Limited Rs 34.02 -2.77% Feb 27, 2026
Liven Pharma Limited (r) Rs 0.00 0.00% Feb 28, 2026
Macter International Limited Rs 314.20 -0.25% Feb 27, 2026
 

Shareholding Pattern

Year Individual Institutions Investment Companies Foreign Investors Government Shareholders Other